Guest Editorial Toward individualized breast cancer screening strategies—TMIST September 11, 2020Vol.46 No.34By Etta D. Pisano, Constantine A. Gatsonis, Peter J. O'Dwyer and Mitchell D. Schnall
Conversation with The Cancer Letter Mitch Schnall: “We don’t want to lose momentum as this review is happening” September 11, 2020Vol.46 No.34By Paul Goldberg
Mojo Sharpless, “world’s smartest dog,” shows off her talent to kids at NCI’s Camp Fantastic September 04, 2020Vol.46 No.33By Alexandria Carolan
COVID-19 & CancerFreeGuest Editorial Delivering a cancer-free frontier during COVID-19 September 04, 2020Vol.46 No.33By Mary Beckerle
NCI: Targeted therapies for NSCLC drove sharp reduction in lung cancer mortality rate September 04, 2020Vol.46 No.33By Matthew Bin Han Ong
Sharpless lays out a scenario for achieving 15% payline for RPGsNCAB approves ad hoc group to review TMIST, other detection trials impacted by COVID September 04, 2020Vol.46 No.33By Alexandria Carolan and Paul Goldberg
Free Matthew Ong named to the Poynter, Washington Post Leadership Academy for Diversity in Digital Media August 06, 2020Vol.46 No.32
COVID-19 & CancerFree The Cancer Letter invites oncology leaders to share insight, strategize on COVID-19 August 06, 2020Vol.46 No.32
COVID-19 & CancerFree Gauging the effects of COVID-19 on cancer mortality August 06, 2020Vol.46 No.32
